Literature DB >> 11288792

The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins.

A Sculean1, A Blaes, N Arweiler, E Reich, N Donos, M Brecx.   

Abstract

BACKGROUND: Regenerative treatment with enamel matrix proteins has been shown to promote healing in intrabony defects. However, up to now various postoperative antibiotic regimens have been used in combination with enamel matrix proteins and therefore it cannot be excluded that the results may also be attributable to the effect of the antibiotic treatment. The aim of this randomized, controlled, blinded, clinical investigation was to determine the effect of postsurgical administration of antibiotics on the healing of intrabony periodontal defects treated with enamel matrix proteins.
METHODS: Thirty-four patients each of whom exhibited one deep intrabony defect were randomly treated with either enamel matrix proteins plus antibiotics (test: EMD + AB) or with enamel matrix proteins alone (control: EMD). The antibiotic regimen consisted of a combination of 3 x 375 mg amoxicillin and 3 x 250 mg metronidazole daily for 7 days. The following parameters were recorded at baseline and at 1 year by the same calibrated and blinded investigator: plaque index (PI), gingival index (GI), bleeding on probing (BOP), probing depth (PD), gingival recession (GR), and clinical attachment level (CAL). Power analysis to determine superiority of antibiotic treatment showed that the available sample size would yield 85% power to detect a 1 mm difference.
RESULTS: No statistically significant differences in any of the investigated parameters between the 2 groups were observed at baseline. No serious adverse events such as allergic reactions or abscesses after any of the treatments were observed during the entire study period. The results have shown that in the EMD + AB group the PD decreased from 9.1 +/- 1.5 mm to 4.5 +/- 1.1 mm (P<0.0001) and the CAL changed from 11.0 +/- 1.6 mm to 7.5 +/- 1.4 mm (P<0.0001). In the EMD group the PD decreased from 9.0 +/- 1.7 mm to 4.3 +/- 1.7 mm (P <0.0001) and the CAL changed from 10.6 +/- 1.6 mm to 7.3 +/- 1.5 mm (P <0.0001). There were no significant differences in any of the investigated parameters between the 2 groups.
CONCLUSIONS: It can be concluded that the systemic administration of amoxicillin and metronidazole adjacent to the use of EMD for the surgical treatment of intrabony periodontal defects does not produce statistically superior PD reduction and CAL gain when compared to treatment with EMD alone. Hence, the present results do not support the routine administration of amoxicillin and metronidazole following regenerative treatment with EMD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11288792     DOI: 10.1902/jop.2001.72.2.190

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  9 in total

1.  Treatment of intrabony periodontal defects in controlled diabetic patients with an enamel matrix derivative: a split-mouth randomized clinical trial.

Authors:  Renata Cimões; Leógenes M Santiago; Arnaldo de França Caldas Júnior; Bruna de Carvalho Farias Vajgel; Jeniffer Perussolo; Nikolaos Donos
Journal:  Clin Oral Investig       Date:  2021-10-13       Impact factor: 3.606

Review 2.  Enamel matrix derivative (Emdogain(R)) for periodontal tissue regeneration in intrabony defects.

Authors:  Marco Esposito; Maria Gabriella Grusovin; Nikolaos Papanikolaou; Paul Coulthard; Helen V Worthington
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

3.  Preferences of UK-Based Dentists When Undertaking Root Coverage and Regenerative Procedures: A Pilot Questionnaire Study.

Authors:  M Siaili; D Chatzopoulou; D G Gillam
Journal:  Int J Dent       Date:  2014-01-28

4.  Enamel matrix protein derivatives: role in periodontal regeneration.

Authors:  Vandana J Rathva
Journal:  Clin Cosmet Investig Dent       Date:  2011-12-01

5.  Enamel matrix derivative protein enhances production of matrixmetalloproteinase-2 by osteoblasts.

Authors:  Seiji Goda; Hiroshi Inoue; Osamu Takeuchi; Yosuke Ujii; Eisuke Domae; Takashi Ikeo
Journal:  BMC Oral Health       Date:  2014-07-10       Impact factor: 2.757

6.  EMD in periodontal regenerative surgery modulates cytokine profiles: A randomised controlled clinical trial.

Authors:  Oscar Villa; Johan C Wohlfahrt; Odd Carsten Koldsland; Steven J Brookes; Staale P Lyngstadaas; Anne M Aass; Janne E Reseland
Journal:  Sci Rep       Date:  2016-03-15       Impact factor: 4.379

7.  Construction of Radial Defect Models in Rabbits to Determine the Critical Size Defects.

Authors:  Ming-Dong Zhao; Jian-Shu Huang; Xin-Chao Zhang; Ke-Ke Gui; Min Xiong; Wang-Ping Yin; Feng-Lai Yuan; Guo-Ping Cai
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

8.  Effect of systemic antibiotics on the outcomes of regenerative periodontal surgery in intrabony defects: a randomized, controlled, clinical study.

Authors:  Małgorzata Pietruska; Ewa Dolińska; Robert Milewski; Anton Sculean
Journal:  Clin Oral Investig       Date:  2020-10-13       Impact factor: 3.573

9.  Adjunctive Effect of Systemic Antibiotics in Regenerative/Reconstructive Periodontal Surgery-A Systematic Review with Meta-Analysis.

Authors:  Luigi Nibali; Jacopo Buti; Luigi Barbato; Francesco Cairo; Filippo Graziani; Søren Jepsen
Journal:  Antibiotics (Basel)       Date:  2021-12-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.